Abiomed, Inc. Gains 49.88%
Tue, Nov 01, 2022 at 07:27 PM
Abiomed, Inc. (ABMD:NASDAQ) soared at $377.82, representing a gain of 49.9%. On Tue, Nov 01, 2022, ABMD:NASDAQ touched a New 2-Week High of $377.82. The stock appeared on our News Catalysts scanner on Tue, Nov 01, 2022 at 06:37 PM in the 'ACQUISITION' category. From Tue, Oct 18, 2022, the stock recorded 50.00% Up Days and 27.27% Green Days
About Abiomed, Inc. (ABMD:NASDAQ)
Abiomed Inc is a medical device company. It provides mechanical circulatory support devices to aid heart recovery to heart failure patients.
Top 10 Gainers:
- Abiomed, Inc. (ABMD:NASDAQ), 49.88%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 46.63%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 44%
- Ucommune International Ltd (UK:NASDAQ), 34.65%
- Safe-T Group Ltd (SFET:NASDAQ), 30.7%
- Aravive, Inc. (ARAV:NASDAQ), 30.53%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 25.13%
- IDEX Biometrics ASA (IDBA:NASDAQ), 23.01%
- Harsco Corporation (HSC:NYSE), 22.5%